Skip to Content

CAR-T Will Transform the Treatment of Malignant Diseases, But Challenges Remain in Selection, Logistics, and Toxicity

Interview:
CAR-T therapy is evolving rapidly, and we have only seen the beginning of this revolution in cancer treatment. Julian Hamfjord, Consultant Clinical Oncologist at the lymphoma section of Oslo University Hospital, shares his insights in this interview.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top